Zealand Pharma
280.50 DKK
-5.75 %
Less than 1K followers
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Zealand Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.4 | 9.1 | 62.7 | 8.1 | 9,088.3 | 49.6 | 68.9 | 9,214.9 |
| EBITDA | -349.4 | -399.3 | -1,272.2 | -407.0 | 8,338.4 | -461.3 | -483.3 | 6,986.8 |
| EBIT | -349.4 | -399.3 | -1,272.2 | -407.0 | 8,338.4 | -461.3 | -510.6 | 6,959.4 |
| EBIT-% | -7,905.2 % | -4,411.9 % | -2,029.4 % | -5,030.1 % | 91.7 % | -930.7 % | -741.0 % | 75.5 % |
| Profit before taxes | -267.8 | -291.6 | -1,083.5 | -336.7 | 8,111.0 | -366.7 | -406.5 | 7,001.1 |
| Net income | -266.4 | -291.0 | -1,078.8 | -335.3 | 7,573.7 | -404.2 | -379.1 | 6,455.0 |